Oligonucleotide-directed mutagenesis is an important method for modifying specific bases of a DNA sequence (8) . Current approaches include combining inverse polymerase chain reaction (PCR) with long PCR to introduce mutations directly into an intact plasmid template (1, 5, 10) . However, the use of TaqDNA polymerase in these protocols results in a high rate of base mis-incorporation (3, 7) . Moreover, the inherent terminal transferase-like activity of the enzyme results in 3 ′ overhangs that must be blunt-ended before ligation (2) . Screening of the clones is also laborious, if direct selection of the desired mutations is not possible.
Our approach to this technique substitutes PwoDNA Polymerase (Boehringer Mannheim, Laval, QC, Canada) for Taqpolymerase and uses the mutagenic primers, not only in long distance inverse PCR, but also as probes for differential screening of transformed colonies.
PwoDNA polymerase has a highly processive 5 ′→3 ′ DNA polymerase activity. Unlike Taq , Pwohas 3 ′→5 ′ exonuclease "proofreading" activity and generates blunt-ended amplification products that can be directly phosphorylated and ligated. The enzyme also has a longer half-life at high temperatures as compared to Taq . Thus, enzyme stabilizing agents, such as glycerol, are not necessary. We successfully used PwoDNA polymerase in a long distance (6.2 kb), inverse PCR as outlined below, to eliminate splice acceptor sites in the cloned E6/E7 open reading frame (ORF) of human papillomavirus type 16 (HPV-16).
For long distance inverse PCR, the primer pairs are designed to anneal "back to back" on the double-stranded template. A separate pair of primers is required to alter each of the two splice acceptor sites located at nucleotide 409 and nucleotide 526 in the HPV-16 E6/E7 ORF. The mutagenic primer of each pair changes the last nucleotide at the 3 ′ end of the first intron and the first nucleotide at the 5 ′ end of the second exon, destroying the splice consensus sequence. Since the 3 ′→5 ′ exonuclease activity of Pwo will target singlestranded DNA, the mutagenic bases must be centrally located in the PCR primer. The second primer of each pair is complementary to the wild-type template ( Table 1 ).
The PCR mixture contains 100 pmol of plasmid template DNA, 25 mM KCl, 10 mM Tris-HCl (pH 8. PwoDNA polymerase requires a slightly more alkaline buffer than Taq . The higher pH can affect the stability of the deoxynucleotides (dNTPs), thus these are added to the PCR immediately before the final addition of Pwo . To promote efficient primer annealing and decrease template "snap-back", DMSO is included in the PCR as a destabilizing agent. The amplification cycle consists of an initial denaturation step at 94°C for 4 min, followed by 40 cycles of amplification with denaturation at 94°C for 1 min, primer annealing at 46°C for 1 min for the nucleotide 409 mutation and at 44°C for 1 min for the nucleotide 526 mutation and primer extension at 72°C for 6 min. The annealing temperature for the mutagenic primers is lowered from the temperature of dissociation (T d ) of the primer by 6°C for each base mismatch. The final extension step is carried out for 10 min.
The PCR products are purified by using a CHROMA SPIN™-100 column (CLONTECH-Bio/Can Scientific, Mississauga, ON, Canada) to remove excess primers, nucleotides and incomplete amplification products of less than 100 bp in size. While incomplete amplification products remain, these molecules are not viable in a bacterial host. The purified amplification Vol. 22, No. 1 (1997) Benchmark s products are directly phosphorylated, then ligated and transformed into a suitable host by using standard protocols (9).
Since we were unable to select directly for clones containing the desired plasmid mutation, we devised a quick method of differentially screening bacterial colonies. To identify the colonies containing mutated plasmids from those containing wild-type template plasmid, colony lifts were screened by using primers p409m and p526m, containing the base changes, as probes ( Table 1 ). The probes were 5 ′ end-labeled with [ γ -32 P]ATP by using a 5 ′ DNA end-labeling kit (Boehringer Mannheim) according to the manufacturer's instructions. Hybridization was carried out under highly stringent conditions equal to the T d of the probes. For primers p409m and p526m, hybridization was carried out at 58°C and 56°C, respectively.
Colony lifts were pre-hybridized for 1.5 h, then 12.5 pmol of 5 ′ end-labeled probe were added in 25 mL of hybridization buffer, and hybridization with shaking was carried out for 1 h in a water bath set at 58°or 56°C. The colony lifts were washed in buffer containing 6 × sodium sodium citrate (SSC) and 0.1% sodium dodecyl sulfate (SDS), pre-warmed to the respective hybridization temperature, for 15 min. This was followed by a second 15-min wash in prewarmed buffer containing 2 ×SSC and 0.1% SDS. Colony lifts were autoradiographed with an intensifying screen overnight at -70°C. Since the probes were 100% homologous to the plasmids containing the mutated sequence, the probes bound preferentially to the colonies containing the desired mutated plasmids. Background hybridization to colonies containing wildtype plasmid was not evident (data not shown), although approximately 50% of the colonies arising on selective plates contained wild-type plasmid. Therefore, efficient selection of the desired colonies was facilitated by this screening procedure. DNA sequencing was used subsequently to verify that the correct mutation had taken place (data not shown).
By optimizing conditions for long distance inverse PCR and substituting Pwo DNA polymerase for Taq , we simplified existing methods of PCR-based oligonucleotide-directed mutagenesis. While other procedures have used polymerases with greater fidelity than Taq such as Vent polymerase (6) or r Tth(4), these protocols rely on incorporation of restriction sites into primer sequences and screening of clones by laborious plasmid miniprep and restriction digest analysis.
The differential screening approach used here increases the efficiency of the process by essentially eliminating selection of undesired clones. Without the screening step, however, there is a significant background of template plasmid transformants. Other investigators have successfully used Dpn I restriction as a final treatment to effectively eliminate methylated template plasmid DNA before transformation (4) . This may be a useful adjunct to our procedure.
While we successfully used the technique to mutate splice acceptor sites in the cloned HPV-16 E6/E7 ORF, the procedure should work equally well for introducing deletions, insertions and base substitutions in any cloned sequence or circular genome. 
